Twin Focus Capital Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,664
Closed -$207K 227
2022
Q4
$207K Sell
2,664
-911
-25% -$73.8K 0.04% 207
2022
Q3
$289K Buy
3,575
+129
+4% +$11.6K 0.07% 149
2022
Q2
$309K Sell
3,446
-103
-3% -$10.4K 0.07% 145
2022
Q1
$394K Buy
3,549
+148
+4% +$15.6K 0.08% 132
2021
Q4
$352K Sell
3,401
-211
-6% -$24.4K 0.07% 146
2021
Q3
$453K Buy
3,612
+508
+16% +$65.8K 0.11% 107
2021
Q2
$385K Buy
3,104
+1,029
+50% +$129K 0.09% 120
2021
Q1
$245K Buy
2,075
+5
+0.2% +$586 0.07% 130
2020
Q4
$242K Buy
2,070
+5
+0.2% +$550 0.07% 133
2020
Q3
$215K Buy
+2,065
New +$207K 0.08% 128
2016
Q4
Sell
-2,674
Closed -$231K 93
2016
Q3
$231K Buy
+2,674
New +$233K 0.16% 68

Other funds holding MDT

Twin Focus Capital Partners's MDT Position: Q1 2023 in Review

Twin Focus Capital Partners sold out of Medtronic (MDT) in Q1 2023, closing a stake of 2,664 shares — an estimated $207K sold.

Twin Focus Capital Partners first reported a position in MDT in Q3 2016 and held it in 11 quarters. The position peaked at $453K in Q3 2021. 1,991 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Twin Focus Capital Partners reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • Twin Focus Capital Partners sold 2,664 Medtronic shares in Q1 2023, an estimated $207K.
  • Twin Focus Capital Partners first reported a position in Medtronic in Q3 2016 and held it in 11 quarters.
  • Twin Focus Capital Partners's Medtronic position peaked at $453K in Q3 2021.
  • 1,991 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Twin Focus Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.